Laura Quock

Laura was previously Senior Director of Corporate Development at Gilead, where she successfully led and closed the acquisition of MiroBio as well as contributed to multiple other strategic transactions, including in-licensing, out-licensing and equity investments across oncology and immunology therapeutic areas. Before Gilead, Laura held various positions at Genentech, AbbVie and Abbott Laboratories. She received an MBA and M.S. ChE from University of California, Berkeley and a B.S. ChE from Purdue University.